在不同的人类癌症中与PD-1共同表达T细胞共抑制和共刺激分子的差异
Ahmad A Tarhini1, Dale Hedges2, Aik Choon Tan3
1Departments of Cutaneous Oncology and Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
概括
研究PD-1 (编程细胞死亡蛋白1) 与免疫检查点的共同表达,揭示了免疫治疗的多种组合理由. 不同的癌症表现出不同的共抑制和共刺激分子表达模式,指导量身定制的治疗策略.
科学领域:
- 免疫学和瘤学
- 癌症基因组学和转录基因组学
- 翻译癌症研究 翻译癌症研究
背景情况:
- 免疫检查点抑制剂 (ICI) 治疗,特别是PD-1阻断,在癌症治疗中显示出显著的前景.
- 了解PD-1和其他免疫检查点之间的相互作用对于优化组合免疫疗法至关重要.
- 不同类型的癌症可能会从不同的免疫调节剂组合中受益.
研究的目的:
- 通过13个免疫检查点 (共抑制和共刺激分子) 检查PD-1的mRNA联合表达水平.
- 在不同类型的癌症中,研究将PD-1封锁与其他免疫调节剂结合在一起的理由.
- 分析来自癌症患者的现实世界的临床和转录基因数据.
主要方法:
- 使用预期最大化 (RSEM) 的RNA-Seq对mRNA联合表达的分析.
- 利用了来自总癌症护理协议和Avatar®项目的现实世界临床和转录组数据.
- 使用SciPy 1.7.0计算了Pearson的R系数和P值,以评估相关性.
主要成果:
- 与免疫检查点的PD-1联合表达模式在恶性瘤之间有显著差异.
- 黑色素瘤和尿癌显示与PD-1共抑制分子的主导共表达,表明T细胞疲劳.
- 卵巢和胰腺癌显示了有利于共同刺激分子的共同表达模式,表明T细胞差异较小.
结论:
- 这些发现支持PD-1阻断免疫治疗的多种组合策略.
- 癌症类型之间独特的共同表达特征为量身定制的组合疗法提供了基础.
- 对这些组合的进一步研究可以提高各种恶性瘤的治疗疗效.
相关概念视频
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
T Cell Activation and Clonal Selection
688
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
688
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491


